▶ 調査レポート

帯状疱疹後神経痛治療の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Post herpetic Neuralgia Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。帯状疱疹後神経痛治療の世界市場2020年:企業別、地域別、種類・用途別 / Global Post herpetic Neuralgia Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / MRC2012B1032資料のイメージです。• レポートコード:MRC2012B1032
• 出版社/出版日:GlobalInfoResearch / 2020年12月24日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、帯状疱疹後神経痛治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。帯状疱疹後神経痛治療の種類別市場規模(抗けいれん薬、皮膚パッチ、その他)、用途別市場規模(病院薬局、オンライン薬局、小売薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Hengrui Medicine、Endo Pharma、Arbor Pharma、Mylan、Assertio Therapeutics、Teva、Teikoku Pharma、
・地域別グローバル市場分析 2015年-2020年
・帯状疱疹後神経痛治療の北米市場(アメリカ、カナダ、メキシコ)
・帯状疱疹後神経痛治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・帯状疱疹後神経痛治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・帯状疱疹後神経痛治療の南米市場(ブラジル、アルゼンチン)
・帯状疱疹後神経痛治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:抗けいれん薬、皮膚パッチ、その他
・用途別分析:病院薬局、オンライン薬局、小売薬局
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Post herpetic Neuralgia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Post herpetic Neuralgia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 1834 million by 2025, from USD 1578.1 million in 2019.

Market segmentation
Post herpetic Neuralgia Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Post herpetic Neuralgia Treatment market has been segmented into:
Anticonvulsants
Skin Patch
Other

By Application, Post herpetic Neuralgia Treatment has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Post herpetic Neuralgia Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Post herpetic Neuralgia Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Post herpetic Neuralgia Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Post herpetic Neuralgia Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Post herpetic Neuralgia Treatment Market Share Analysis
Post herpetic Neuralgia Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Post herpetic Neuralgia Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Post herpetic Neuralgia Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Post herpetic Neuralgia Treatment are:
Pfizer
Hengrui Medicine
Endo Pharma
Arbor Pharma
Mylan
Assertio Therapeutics
Teva
Teikoku Pharma
Among other players domestic and global, Post herpetic Neuralgia Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Post herpetic Neuralgia Treatment Market Overview
1.1 Product Overview and Scope of Post herpetic Neuralgia Treatment
1.2 Classification of Post herpetic Neuralgia Treatment by Type
1.2.1 Global Post herpetic Neuralgia Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Type in 2019
1.2.3 Anticonvulsants
1.2.4 Skin Patch
1.2.5 Other
1.3 Global Post herpetic Neuralgia Treatment Market by Application
1.3.1 Overview: Global Post herpetic Neuralgia Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Post herpetic Neuralgia Treatment Market by Regions
1.4.1 Global Post herpetic Neuralgia Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Post herpetic Neuralgia Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Post herpetic Neuralgia Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Post herpetic Neuralgia Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Post herpetic Neuralgia Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Post herpetic Neuralgia Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Post herpetic Neuralgia Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hengrui Medicine
2.2.1 Hengrui Medicine Details
2.2.2 Hengrui Medicine Major Business
2.2.3 Hengrui Medicine SWOT Analysis
2.2.4 Hengrui Medicine Product and Services
2.2.5 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Endo Pharma
2.3.1 Endo Pharma Details
2.3.2 Endo Pharma Major Business
2.3.3 Endo Pharma SWOT Analysis
2.3.4 Endo Pharma Product and Services
2.3.5 Endo Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arbor Pharma
2.4.1 Arbor Pharma Details
2.4.2 Arbor Pharma Major Business
2.4.3 Arbor Pharma SWOT Analysis
2.4.4 Arbor Pharma Product and Services
2.4.5 Arbor Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Assertio Therapeutics
2.6.1 Assertio Therapeutics Details
2.6.2 Assertio Therapeutics Major Business
2.6.3 Assertio Therapeutics Product and Services
2.6.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Product and Services
2.7.4 Teva Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teikoku Pharma
2.8.1 Teikoku Pharma Details
2.8.2 Teikoku Pharma Major Business
2.8.3 Teikoku Pharma Product and Services
2.8.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Post herpetic Neuralgia Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Post herpetic Neuralgia Treatment Players Market Share
3.2.2 Top 10 Post herpetic Neuralgia Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Post herpetic Neuralgia Treatment Revenue and Market Share by Regions
4.2 North America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
5 North America Post herpetic Neuralgia Treatment Revenue by Countries
5.1 North America Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
5.2 USA Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
6 Europe Post herpetic Neuralgia Treatment Revenue by Countries
6.1 Europe Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
6.2 Germany Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
6.4 France Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Countries
7.1 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
7.2 China Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
7.5 India Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
8 South America Post herpetic Neuralgia Treatment Revenue by Countries
8.1 South America Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
8.2 Brazil Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Post herpetic Neuralgia Treatment by Countries
9.1 Middle East & Africa Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Post herpetic Neuralgia Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Post herpetic Neuralgia Treatment Market Forecast by Type (2019-2024)
10.3 Anticonvulsants Revenue Growth Rate (2015-2025)
10.4 Skin Patch Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Post herpetic Neuralgia Treatment Market Segment by Application
11.1 Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2015-2020)
11.2 Post herpetic Neuralgia Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Post herpetic Neuralgia Treatment Market Size Forecast (2021-2025)
12.1 Global Post herpetic Neuralgia Treatment Market Size Forecast (2021-2025)
12.2 Global Post herpetic Neuralgia Treatment Market Forecast by Regions (2021-2025)
12.3 North America Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
12.6 South America Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Post herpetic Neuralgia Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Post herpetic Neuralgia Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Post herpetic Neuralgia Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Post herpetic Neuralgia Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Pfizer Corporate Information, Location and Competitors
Table 7. Pfizer Post herpetic Neuralgia Treatment Major Business
Table 8. Pfizer Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Pfizer SWOT Analysis
Table 10. Pfizer Post herpetic Neuralgia Treatment Product and Solutions
Table 11. Pfizer Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Hengrui Medicine Corporate Information, Location and Competitors
Table 13. Hengrui Medicine Post herpetic Neuralgia Treatment Major Business
Table 14. Hengrui Medicine Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Hengrui Medicine SWOT Analysis
Table 16. Hengrui Medicine Post herpetic Neuralgia Treatment Product and Solutions
Table 17. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Endo Pharma Corporate Information, Location and Competitors
Table 19. Endo Pharma Post herpetic Neuralgia Treatment Major Business
Table 20. Endo Pharma Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Endo Pharma SWOT Analysis
Table 22. Endo Pharma Post herpetic Neuralgia Treatment Product and Solutions
Table 23. Endo Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Arbor Pharma Corporate Information, Location and Competitors
Table 25. Arbor Pharma Post herpetic Neuralgia Treatment Major Business
Table 26. Arbor Pharma Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Arbor Pharma SWOT Analysis
Table 28. Arbor Pharma Post herpetic Neuralgia Treatment Product and Solutions
Table 29. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Mylan Corporate Information, Location and Competitors
Table 31. Mylan Post herpetic Neuralgia Treatment Major Business
Table 32. Mylan Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Mylan SWOT Analysis
Table 34. Mylan Post herpetic Neuralgia Treatment Product and Solutions
Table 35. Mylan Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Assertio Therapeutics Corporate Information, Location and Competitors
Table 37. Assertio Therapeutics Post herpetic Neuralgia Treatment Major Business
Table 38. Assertio Therapeutics Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Assertio Therapeutics SWOT Analysis
Table 40. Assertio Therapeutics Post herpetic Neuralgia Treatment Product and Solutions
Table 41. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Teva Corporate Information, Location and Competitors
Table 43. Teva Post herpetic Neuralgia Treatment Major Business
Table 44. Teva Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Teva SWOT Analysis
Table 46. Teva Post herpetic Neuralgia Treatment Product and Solutions
Table 47. Teva Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Teikoku Pharma Corporate Information, Location and Competitors
Table 49. Teikoku Pharma Post herpetic Neuralgia Treatment Major Business
Table 50. Teikoku Pharma Post herpetic Neuralgia Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Teikoku Pharma SWOT Analysis
Table 52. Teikoku Pharma Post herpetic Neuralgia Treatment Product and Solutions
Table 53. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Post herpetic Neuralgia Treatment Revenue (Million USD) by Players (2015-2020)
Table 55. Global Post herpetic Neuralgia Treatment Revenue Share by Players (2015-2020)
Table 56. Global Post herpetic Neuralgia Treatment Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Post herpetic Neuralgia Treatment Revenue Market Share by Regions (2015-2020)
Table 58. North America Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
Table 59. North America Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Table 60. Europe Post herpetic Neuralgia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Post herpetic Neuralgia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Post herpetic Neuralgia Treatment Revenue by Countries (2015-2020)
Table 63. South America Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Post herpetic Neuralgia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Table 66. Global Post herpetic Neuralgia Treatment Revenue (Million USD) by Type (2015-2020)
Table 67. Global Post herpetic Neuralgia Treatment Revenue Share by Type (2015-2020)
Table 68. Global Post herpetic Neuralgia Treatment Revenue Forecast by Type (2021-2025)
Table 69. Global Post herpetic Neuralgia Treatment Revenue by Application (2015-2020)
Table 70. Global Post herpetic Neuralgia Treatment Revenue Share by Application (2015-2020)
Table 71. Global Post herpetic Neuralgia Treatment Revenue Forecast by Application (2021-2025)
Table 72. Global Post herpetic Neuralgia Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Post herpetic Neuralgia Treatment Picture
Figure 2. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type in 2019
Figure 3. Anticonvulsants Picture
Figure 4. Skin Patch Picture
Figure 5. Other Picture
Figure 6. Post herpetic Neuralgia Treatment Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Post herpetic Neuralgia Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Post herpetic Neuralgia Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Post herpetic Neuralgia Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Post herpetic Neuralgia Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Post herpetic Neuralgia Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Post herpetic Neuralgia Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Post herpetic Neuralgia Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Countries in 2019
Figure 43. China Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Post herpetic Neuralgia Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Post herpetic Neuralgia Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Post herpetic Neuralgia Treatment Revenue Share by Type in 2019
Figure 60. Global Post herpetic Neuralgia Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Anticonvulsants Revenue Growth Rate (2015-2020)
Figure 62. Global Skin Patch Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Post herpetic Neuralgia Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Post herpetic Neuralgia Treatment Revenue Share by Application in 2019
Figure 66. Global Post herpetic Neuralgia Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Post herpetic Neuralgia Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Post herpetic Neuralgia Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel